Biosensors that measure glucose are now available without a prescription. Wearing one burst my wellness bubble in ways I wasn ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...

SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.

Dexcom unveiled its Dexcom G7 continuous glucose monitoring (CGM) for people with diabetes age two years and older in ...

The results highlight the viability and benefits of a standardized CGM policy in enhancing inpatient diabetes management. Among the 27 nurses who completed the user experience surveys, 74% found ...

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...

DexCom ( DXCM -1.08%) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...

Texas residents who were exposed to greater levels of toxic metals were found to develop markers for type 2 diabetes earlier.